These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 17649802)
1. Fecal pyruvate kinase-M2 (tumor M2-PK) measurement: a new screening concept for colorectal cancer. Ewald N; Schaller M; Bayer M; Akinci A; Bretzel RG; Kloer HU; Hardt PD Anticancer Res; 2007; 27(4A):1949-52. PubMed ID: 17649802 [TBL] [Abstract][Full Text] [Related]
2. [Pyruvate kinase M2 (tumor M2-PK) as a screening tool for colorectal cancer (CRC). A review of current published data]. Ewald N; Toepler M; Akinci A; Kloer HU; Bretzel RG; Hardt PD Z Gastroenterol; 2005 Dec; 43(12):1313-7. PubMed ID: 16315127 [TBL] [Abstract][Full Text] [Related]
3. Measurement of fecal pyruvate kinase type M2 (tumor M2-PK) concentrations in patients with gastric cancer, colorectal cancer, colorectal adenomas and controls. Hardt PD; Toepler M; Ngoumou B; Rupp J; Kloer HU Anticancer Res; 2003; 23(2A):851-3. PubMed ID: 12820312 [TBL] [Abstract][Full Text] [Related]
4. Stool test for colorectal cancer screening--it's time to move! Loitsch SM; Shastri Y; Stein J Clin Lab; 2008; 54(11-12):473-84. PubMed ID: 19216253 [TBL] [Abstract][Full Text] [Related]
5. Fecal pyruvate kinase concentrations (ELISA based on a combination of clone 1 and clone 3 antibodies) for gastric cancer screening. Hardt PD; Toepler M; Ngoumou B; Rupp J; Kloer HU Anticancer Res; 2003; 23(2A):855-7. PubMed ID: 12820313 [TBL] [Abstract][Full Text] [Related]
6. [Comparison of different stool tests for the detection of cancer of the colon]. Vogel T; Driemel C; Hauser A; Hansmann A; Lange S; Jonas M; Möslein G Dtsch Med Wochenschr; 2005 Apr; 130(14):872-7. PubMed ID: 15800820 [TBL] [Abstract][Full Text] [Related]
7. A new fecal calprotectin test for colorectal neoplasia. Clinical results and comparison with previous method. Johne B; Kronborg O; Tøn HI; Kristinsson J; Fuglerud P Scand J Gastroenterol; 2001 Mar; 36(3):291-6. PubMed ID: 11305517 [TBL] [Abstract][Full Text] [Related]
8. Tumor M2 pyruvate kinase: a tumor marker and its clinical application in gastrointestinal malignancy. Hardt PD; Ewald N Expert Rev Mol Diagn; 2008 Sep; 8(5):579-85. PubMed ID: 18785806 [TBL] [Abstract][Full Text] [Related]
9. Colorectal cancer detection in an asymptomatic population: fecal immunochemical test for hemoglobin vs. fecal M2-type pyruvate kinase. Caviglia GP; Cabianca L; Fagoonee S; Gili FM Biochem Med (Zagreb); 2016; 26(1):114-20. PubMed ID: 26981025 [TBL] [Abstract][Full Text] [Related]
10. Comparison of faecal M2-PK and FIT in a population-based bowel cancer screening cohort. Leen R; Seng-Lee C; Holleran G; O'Morain C; McNamara D Eur J Gastroenterol Hepatol; 2014 May; 26(5):514-8. PubMed ID: 24699725 [TBL] [Abstract][Full Text] [Related]
11. Faecal tumour pyruvate kinase M2: not a good marker for the detection of colorectal adenomas. Shastri YM; Stein JM Br J Cancer; 2008 Oct; 99(8):1366; author reply 1367. PubMed ID: 18827821 [No Abstract] [Full Text] [Related]
12. Fecal cyclooxygenase 2 plus matrix metalloproteinase 7 mRNA assays as a marker for colorectal cancer screening. Takai T; Kanaoka S; Yoshida K; Hamaya Y; Ikuma M; Miura N; Sugimura H; Kajimura M; Hishida A Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1888-93. PubMed ID: 19505922 [TBL] [Abstract][Full Text] [Related]
13. Improved fecal DNA test for colorectal cancer screening. Itzkowitz SH; Jandorf L; Brand R; Rabeneck L; Schroy PC; Sontag S; Johnson D; Skoletsky J; Durkee K; Markowitz S; Shuber A Clin Gastroenterol Hepatol; 2007 Jan; 5(1):111-7. PubMed ID: 17161655 [TBL] [Abstract][Full Text] [Related]
14. [Clinical significance of blood and fecal tumor M2-pyruvate kinase expression in patients with colorectal cancer]. Li Y; Wang JJ Nan Fang Yi Ke Da Xue Xue Bao; 2011 Dec; 31(12):2087-9. PubMed ID: 22200720 [TBL] [Abstract][Full Text] [Related]
16. Tumor M2-pyruvate kinase: a promising tumor marker in the diagnosis of gastro-intestinal cancer. Hardt PD; Ngoumou BK; Rupp J; Schnell-Kretschmer H; Kloer HU Anticancer Res; 2000; 20(6D):4965-8. PubMed ID: 11326648 [TBL] [Abstract][Full Text] [Related]
17. The Usefulness of a Novel Screening Kit for Colorectal Cancer Using the Immunochromatographic Fecal Tumor M2 Pyruvate Kinase Test. Kim YC; Kim JH; Cheung DY; Kim TH; Jun EJ; Oh JW; Kim CW; Chung WC; Kim BW; Kim SS; Kim JI; Park SH; Kim JK Gut Liver; 2015 Sep; 9(5):641-8. PubMed ID: 25473070 [TBL] [Abstract][Full Text] [Related]
18. Improved sensitivity in the diagnosis of gastro-intestinal tumors by fuzzy logic-based tumor marker profiles including the tumor M2-PK. Schneider J; Bitterlich N; Schulze G Anticancer Res; 2005; 25(3A):1507-15. PubMed ID: 16033052 [TBL] [Abstract][Full Text] [Related]
20. Improved diagnosis of colorectal cancer using a combination of fecal occult blood and novel fecal protein markers. Karl J; Wild N; Tacke M; Andres H; Garczarek U; Rollinger W; Zolg W Clin Gastroenterol Hepatol; 2008 Oct; 6(10):1122-8. PubMed ID: 18928937 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]